Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q1686059> ?p ?o }
Showing triples 1 to 44 of
44
with 100 triples per page.
- Q1686059 subject Q15207778.
- Q1686059 abstract "The triple test, also called triple screen, the Kettering test or the Bart's test, is an investigation performed during pregnancy in the second trimester to classify a patient as either high-risk or low-risk for chromosomal abnormalities (and neural tube defects).The term "multiple-marker screening test" is sometimes used instead. This term can encompass the "double test" and "quadruple test" (described below).The Triple screen measures serum levels of AFP, estriol, and beta-hCG, with a 70% sensitivity and 5% false-positive rate. It is complemented in some regions of the United States, as the Quad screen (adding inhibin A to the panel, resulting in an 81% sensitivity and 5% false-positive rate for detecting Down syndrome when taken at 15–18 weeks of gestational age) and other prenatal diagnosis techniques, although it remains widely used in Canada and other countries. A positive screen indicates an increased risk of chromosomal abnormalities (and neural tube defects), and such patients are then referred for more sensitive and specific procedures to receive a definitive diagnosis, often prenatal diagnosis via amniocentesis, although the stronger screening option of cell-free fetal DNA screening (also popularly known as noninvasive prenatal screening) is frequently offered. The Triple test can be understood as an early predecessor to a long line of subsequent technological improvements. In some American states, such as Missouri, Medicaid reimburses only for the Triple test and not other potentially more accurate screening tests, whereas California offers Quad tests to all pregnant women.".
- Q1686059 wikiPageExternalLink tripletest.html.
- Q1686059 wikiPageExternalLink b111-5.html.
- Q1686059 wikiPageWikiLink Q1076497.
- Q1686059 wikiPageWikiLink Q110084.
- Q1686059 wikiPageWikiLink Q1136569.
- Q1686059 wikiPageWikiLink Q1163564.
- Q1686059 wikiPageWikiLink Q11995.
- Q1686059 wikiPageWikiLink Q14225730.
- Q1686059 wikiPageWikiLink Q14858822.
- Q1686059 wikiPageWikiLink Q1495674.
- Q1686059 wikiPageWikiLink Q15207778.
- Q1686059 wikiPageWikiLink Q1521567.
- Q1686059 wikiPageWikiLink Q159979.
- Q1686059 wikiPageWikiLink Q162564.
- Q1686059 wikiPageWikiLink Q1686059.
- Q1686059 wikiPageWikiLink Q177719.
- Q1686059 wikiPageWikiLink Q202849.
- Q1686059 wikiPageWikiLink Q213410.
- Q1686059 wikiPageWikiLink Q2253111.
- Q1686059 wikiPageWikiLink Q25671.
- Q1686059 wikiPageWikiLink Q26513.
- Q1686059 wikiPageWikiLink Q2781245.
- Q1686059 wikiPageWikiLink Q284219.
- Q1686059 wikiPageWikiLink Q332154.
- Q1686059 wikiPageWikiLink Q3804555.
- Q1686059 wikiPageWikiLink Q3808900.
- Q1686059 wikiPageWikiLink Q407172.
- Q1686059 wikiPageWikiLink Q407983.
- Q1686059 wikiPageWikiLink Q409721.
- Q1686059 wikiPageWikiLink Q422284.
- Q1686059 wikiPageWikiLink Q457737.
- Q1686059 wikiPageWikiLink Q473768.
- Q1686059 wikiPageWikiLink Q47715.
- Q1686059 wikiPageWikiLink Q503642.
- Q1686059 wikiPageWikiLink Q5150911.
- Q1686059 wikiPageWikiLink Q548213.
- Q1686059 wikiPageWikiLink Q736944.
- Q1686059 wikiPageWikiLink Q844717.
- Q1686059 wikiPageWikiLink Q989120.
- Q1686059 wikiPageWikiLink Q998273.
- Q1686059 comment "The triple test, also called triple screen, the Kettering test or the Bart's test, is an investigation performed during pregnancy in the second trimester to classify a patient as either high-risk or low-risk for chromosomal abnormalities (and neural tube defects).The term "multiple-marker screening test" is sometimes used instead.".
- Q1686059 label "Triple test".